Examination of Effective Buccal Absorption of Salmon Calcitonin Using Cell-Penetrating Peptide-Conjugated Liposomal Drug Delivery System
Taekwang Keum,Gyubin Noh,Jo-Eun Seo,Santosh Bashyal,Dong Hwan Sohn,Sangkil Lee
DOI: https://doi.org/10.2147/IJN.S335774
IF: 7.033
2022-02-15
International Journal of Nanomedicine
Abstract:Taekwang Keum, 1, 2, &ast Gyubin Noh, 1, 2, &ast Jo-Eun Seo, 1 Santosh Bashyal, 1, 2 Dong Hwan Sohn, 1 Sangkil Lee 1, 2 1 College of Pharmacy, Keimyung University, Daegu, Republic of Korea; 2 Center for Forensic Pharmaceutical Science, Daegu, Republic of Korea &astThese authors contributed equally to this work Correspondence: Sangkil Lee, College of Pharmacy, Keimyung University, 1095 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, Republic of Korea, Tel +82-53-580-6655, Fax +82-53-580-5164, Email Introduction: The buccal route has been considered an attractive alternative delivery route for injectable formulations. Cell-penetrating peptides (CPPs) are gaining increased attention for their cellular uptake and tissue permeation effects. This study was aimed to evaluate the in vitro and ex vivo permeation-enhancing effect of penetratin-conjugated liposomes for salmon calcitonin (sCT) in TR146 human buccal cells and porcine buccal tissues. Methods: Penetratin was conjugated to phospholipids through a maleimide-thiol reaction. Liposomes were prepared and sCT was encapsulated using a thin-film hydration method. Physical properties such as particle size, zeta potential, encapsulation efficiency, and morphological images via transmission electron microscopy were obtained. Cellular uptake studies were conducted using flow cytometry (FACS) and confocal laser scanning microscopy (CLSM). A cell permeation study was performed using a Transwell ® assay, and permeation through porcine buccal tissue was evaluated. The amount of sCT permeated was quantified using an ELISA kit and was optically observed using CLSM. Results: The particle size of penetratin-conjugated liposomes was approximately 123.0 nm, their zeta potential was +29.6 mV, and their calcitonin encapsulation efficiency was 18.0%. In the cellular uptake study using FACS and CLSM, stronger fluorescence was observed in penetratin-conjugated liposomes compared with the solution containing free sCT and control liposomes. Likewise, the amount of sCT permeated from penetratin-conjugated liposomes was higher than that from the free sCT solution and control liposomes by 5.8-fold across TR146 cells and 91.5-fold across porcine buccal tissues. Conclusion: Penetratin-conjugated liposomes are considered a good drug delivery strategy for sCT via the buccal route. Keywords: buccal drug delivery, peptide delivery, penetratin, liposomes, TR146 cells, porcine buccal tissues Calcitonin is a hormone consisting of 32 amino acids long secreted from the C cells of the mammalian thyroid. This hormone was discovered by Copp et al, where they found that it lowers blood calcium levels. 1 Calcitonin is an endogenous physiological hormone that inhibits bone resorption and is used as a treatment for diseases related to bone resorption, such as postmenopausal osteoporosis, to reduce the adherence of osteoclasts and osteoclast formation. 2,3 Other types of synthetic or recombinant calcitonin, such as human calcitonin, porcine calcitonin, and salmon calcitonin (sCT), have been used for medical purposes. Among them, sCT has been the most widely used, as it has a 40–50-fold higher efficacy than human calcitonin. 4–6 Oral administration is a drug delivery route preferred in clinical practice and is associated with high patient compliance. 7 However, biopharmaceuticals such as sCT have a high molecular weight and hydrophilicity. There are many difficulties facing drug delivery through the gastrointestinal (GI) tract. Protease action, hydrolysis, and hepatic first-pass effects occur in the GI tract. To overcome such limitations, intravenous injection is usually used. 8 As biopharmaceuticals are substances with short half-life, they are administered frequently. Hence, patient compliance is low due to needle phobia, pain caused by intravenous injection, and difficulties in self-administration. 7,9,10 Various mucous membranes, such as the nasal, rectal, vaginal, ocular, pulmonary, and buccal membranes, are considered alternative drug delivery methods for the delivery of biopharmaceutical substances. 10 In contrast to oral administration, alternative drug delivery methods offer a milder environment for the absorption of biopharmaceuticals. Compared to other non-oral administration routes, the buccal route may lead to high patient compliance due to its easy administration and lower incidence of irritation. 8,9 The buccal route is abundant in blood vessels, and the administered drug can directly enter the jugular veins via the blood vessels, allowing its absorption into the sy -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology